[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 38 of about 38
1. Tewari A, Jhaveri J, Rao S, Yadav R, Bartsch G, Te A, Ioffe E, Pineda M, Mudaliar S, Nguyen L, Libertino J, Vaughan D: Total reconstruction of the vesico-urethral junction. BJU Int; 2008 Apr;101(7):871-7
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Total reconstruction of the vesico-urethral junction.
  • OBJECTIVE: We describe a novel technique of total vesico-urethral reconstruction, which combines the tactics of previous surgeons, and compare the outcome of our innovative changes for return to early continence with prostatectomies with no or partial reconstruction of the vesico-urethral junction.
  • Patients in 2005 (214) served as a control group, they received no additional methods to provide support to the vesico-urethral junction; a standard anastomosis was made.
  • Patients in 2006 (304) received an anterior reconstruction only, to provide additional vesico-urethral anastomotic support.
  • Patients in 2007 (182) received the total reconstructive procedure, which included an anterior reconstruction and posterior reconstruction.
  • Outcome data were collected using standardized health-related quality-of-life measures, which included the Expanded Prostate Cancer Index Composite survey, International Prostate Symptom Score, International Index of Erectile Function, and then re-verified by telephone interview with a standardized questionnaire.
  • The percentage of patients who had achieved continence in the anterior reconstruction group were 27%, 59%, 77%, 86%, and 91%, respectively.
  • At all the follow-up intervals the continence rate was significantly less in the control group than in the anterior reconstruction group and the total reconstruction group (P < 0.01).
  • No adverse effects have been observed because of its employment and our data validates that it does provide a statistically significant early return to continence compared with no reconstructive efforts or with only anterior reconstructive efforts.
  • [MeSH-major] Prostatectomy / methods. Prostatic Neoplasms / surgery. Urethra / surgery. Urinary Bladder / surgery

  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] BJU Int. 2011 Feb;107(4):525-6 [21276175.001]
  • [CommentIn] Nat Clin Pract Urol. 2008 Oct;5(10):530-1 [18779829.001]
  • (PMID = 18321319.001).
  • [ISSN] 1464-410X
  • [Journal-full-title] BJU international
  • [ISO-abbreviation] BJU Int.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


2. Gonzaga LF, Freitas FC, Tavares JM: Aggressive vaginal angiomyxoma mimicking urethral tumor. Int Braz J Urol; 2005 Sep-Oct;31(5):475-6
MedlinePlus Health Information. consumer health - Vaginal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Aggressive vaginal angiomyxoma mimicking urethral tumor.
  • This is a case report of a 32-year-old female patient with a neoplasia mimicking a urethral tumor.
  • Following anterior pelvic exanteration, vulvectomy, bilateral inguinal lymphadenectomy, the pathological study established the diagnosis of aggressive vaginal angiomyxoma, CD-34 labeled.
  • [MeSH-major] Myxoma / diagnosis. Urethral Neoplasms / diagnosis. Vaginal Neoplasms / diagnosis
  • [MeSH-minor] Adult. Antigens, CD34 / analysis. Biomarkers, Tumor / analysis. Diagnosis, Differential. Disease-Free Survival. Female. Follow-Up Studies. Humans. Immunohistochemistry

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16255796.001).
  • [ISSN] 1677-5538
  • [Journal-full-title] International braz j urol : official journal of the Brazilian Society of Urology
  • [ISO-abbreviation] Int Braz J Urol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Brazil
  • [Chemical-registry-number] 0 / Antigens, CD34; 0 / Biomarkers, Tumor
  •  go-up   go-down


3. Tewari AK, Srivastava A, Mudaliar K, Tan GY, Grover S, El Douaihy Y, Peters D, Leung R, Yadav R, John M, Wysock J, Vaughan ED, Muir S, Amin MB, Rubin M, Tu J, Akthar M, Shevchuk M: Anatomical retro-apical technique of synchronous (posterior and anterior) urethral transection: a novel approach for ameliorating apical margin positivity during robotic radical prostatectomy. BJU Int; 2010 Nov;106(9):1364-73
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Anatomical retro-apical technique of synchronous (posterior and anterior) urethral transection: a novel approach for ameliorating apical margin positivity during robotic radical prostatectomy.
  • OBJECTIVE: To describe a novel synchronous approach to apical dissection during robotic-assisted radical prostatectomy (RARP) which augments circumferential visual appreciation of the prostatic apex and membranous urethra anatomy, and assess its effect on apical margin positivity.
  • Conventional apical transection after early ligation of the dorsal venous complex (DVC) remains suboptimal, as this approach obscures visualization of the intersection between prostatic apex and membranous urethra, leading to inadvertent apical capsulotomy and eventual margin positivity.
  • A synchronous urethral transection commenced via a retro-apical approach was adopted in 209 consecutive patients undergoing RARP by one surgeon (A.T.) between April to September 2009.
  • The apical margin rates for this group were compared with those of 1665 previous patients who received conventional urethral transection via an anterior approach after DVC ligation.
  • The location of PSMs was identified as apex, posterior, posterolateral, bladder neck, anterior, base, or multifocal.
  • RESULTS: Patients receiving synchronous urethral transection had significantly lower apical PSM rates than the control group (1.4% vs 4.4%, P = 0.04).
  • This marked improvement in the retro-apical group occurred despite a significantly higher incidence of aggressive cancer (≥ pT3a) documented on final specimen pathology (16% vs 10%, P = 0.027).Technical difficulty was encountered in three of 209 study patients, in whom urethral transection had to be completed using the classic anterior approach.
  • CONCLUSION: Improved circumferential visualization of the prostatic apex, membranous urethra and their anatomical intersection facilitates precise dissection of the apex and its surrounding neural scaffold, and optimizes membranous urethral preservation.
  • This has significantly ameliorated apical PSM rates in patients undergoing RARP, despite having to deal with more aggressive cancer on final specimen pathology.
  • [MeSH-major] Neoplasm Recurrence, Local / prevention & control. Prostate / pathology. Prostatectomy / methods. Prostatic Neoplasms / pathology. Robotics. Urethra / pathology

  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2010 THE AUTHORS. JOURNAL COMPILATION © 2010 BJU INTERNATIONAL.
  • (PMID = 20377582.001).
  • [ISSN] 1464-410X
  • [Journal-full-title] BJU international
  • [ISO-abbreviation] BJU Int.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


Advertisement
4. Thibault F, Mouton A, Sibony M, Cussenot O, Sebe P, Gattegno B, Thibault P, Haab F: [Urethral cancer: report of three cases and review of the literature]. Prog Urol; 2008 May;18(5):318-22
Genetic Alliance. consumer health - Urethral cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Urethral cancer: report of three cases and review of the literature].
  • [Transliterated title] Cancer de l'urètre féminin, à propos de trois cas et revue de la littérature.
  • OBJECTIVE: To review the various clinical forms of female urethral cancer in the light of three clinical cases with a review of the corresponding treatment guidelines.
  • METHOD: The authors report three cases of female urethral cancer.
  • Case 2 was a urothelial tumour arising in a urethral diverticulum in a 60-year-old smoker.
  • Case 2 was treated by anterior pelvic exenteration with no adjuvant therapy.
  • Case 3 was initially treated by anterior pelvic exenteration followed by a chemoradiotherapy combination after local recurrence with a favourable course.
  • CONCLUSION: There are many clinical presentations and histological forms of female urethral cancer.
  • The treatment of other lesions comprises anterior pelvic exenteration and platinum- or M-VAC-based chemoradiotherapy.
  • [MeSH-major] Carcinoma / surgery. Urethral Neoplasms / surgery
  • [MeSH-minor] Aged. Female. Humans. Middle Aged. Neoplasm Recurrence, Local / therapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18538278.001).
  • [ISSN] 1166-7087
  • [Journal-full-title] Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie
  • [ISO-abbreviation] Prog. Urol.
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Number-of-references] 15
  •  go-up   go-down


5. Elliott SP, McAninch JW, Chi T, Doyle SM, Master VA: Management of severe urethral complications of prostate cancer therapy. J Urol; 2006 Dec;176(6 Pt 1):2508-13
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Management of severe urethral complications of prostate cancer therapy.
  • PURPOSE: We present our management of urethral stenosis and rectourinary fistula resulting from prostate cancer therapy.
  • MATERIALS AND METHODS: In our prospectively collected urethral reconstruction database we identified patients who underwent reconstruction of urethral stenosis or rectourinary fistula who also received prior treatment for prostate cancer.
  • We documented demographics, prostate cancer pretreatment characteristics, prostate cancer therapy type, urethral reconstruction type and success.
  • RESULTS: A total of 48 patients met the inclusion criteria, including 16 with rectourinary fistula and 32 with urethral stenosis.
  • Urethral complications followed prior radical prostatectomy, brachytherapy, external beam radiotherapy, cryotherapy, thermal ablation and any combination of these procedures.
  • Stenosis repair was successful in 23 of 32 cases (73%) and it differed little between anterior and posterior urethral stenosis.
  • Repair was accomplished by anastomotic urethroplasty in 19 cases, flap urethroplasty in 2, perineal urethrostomy in 2 and a urethral stent in 9.
  • Prior external beam radiotherapy was a risk factor for urethral reconstruction failure.
  • The complexity of fistula management was dictated by fistula size and the presence or absence of coincident urethral stenosis.
  • CONCLUSIONS: Urethral stenosis or rectourethral fistula following prostate cancer therapy can be managed by urethral reconstruction, such that normal voiding via the urethra is maintained, rather than abandoning the urethral outlet and performing heterotopic diversion.
  • [MeSH-major] Urethra / pathology


6. Vaidyanathan S, Soni BM, Mansour P, Singh G, Hughes PL: Invasive carcinoma of urinary bladder in a patient with a spinal cord injury with non-functioning Brindley sacral anterior root stimulator: a case report. Cases J; 2008;1(1):137

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Invasive carcinoma of urinary bladder in a patient with a spinal cord injury with non-functioning Brindley sacral anterior root stimulator: a case report.
  • BACKGROUND: Anterior sacral root stimulation combined with sacral posterior rhizotomy restores bladder function in spinal cord-injured patients suffering from hyperactive bladder.
  • We present a spinal cord injury patient with non-functioning Brindley sacral anterior root stimulator, who developed carcinoma of urinary bladder.
  • This patient underwent implantation of sacral anterior root stimulator in September 1985.
  • The bladder stimulator started giving trouble since 1996 and the patient went back to using indwelling urethral catheter.
  • CONCLUSION: Occurrence of vesical malignancy in this patient with non-functioning bladder stimulator is a timely reminder to all health professionals, and health care managers that concerted efforts should be made to rectify a non-functioning sacral anterior root stimulator as soon as possible.
  • Otherwise, facilities should be made available in the community for the spinal cord injury patient to use intermittent catheterisation and thereby, avoid permanent indwelling catheter, vesical calculi and urine infections, which are risk factors for bladder cancer.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Acta Neurochir Suppl. 2007;97(Pt 1):323-31 [17691393.001]
  • [Cites] Prog Urol. 2007 May;17(3):431-5 [17622071.001]
  • [Cites] BMC Cancer. 2004 Nov 26;4:87 [15566572.001]
  • [Cites] J Urol. 1996 Apr;155(4):1378-81 [8632580.001]
  • [Cites] Arch Physiol Biochem. 1999 Jul;107(3):248-56 [10650355.001]
  • [Cites] J Spinal Cord Med. 2003 Winter;26(4):335-8 [14992333.001]
  • [Cites] Arch Phys Med Rehabil. 2002 Mar;83(3):346-51 [11887115.001]
  • [Cites] Urology. 2002 Feb;59(2):240-4 [11834395.001]
  • [Cites] Spinal Cord. 2001 Nov;39(11):584-8 [11641808.001]
  • [Cites] Cancer Res. 2004 May 1;64(9):3288-95 [15126372.001]
  • (PMID = 18761737.001).
  • [ISSN] 1757-1626
  • [Journal-full-title] Cases journal
  • [ISO-abbreviation] Cases J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2546370
  •  go-up   go-down


7. Hung CF, Lee CH, Hung SW, Chiu KY, Cheng CL, Yang CR, Chen CJ, Li JR: Invasive adenocarcinoma of the prostate with urethral tumor. J Chin Med Assoc; 2010 Feb;73(2):101-3
MedlinePlus Health Information. consumer health - Prostate Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Invasive adenocarcinoma of the prostate with urethral tumor.
  • Metastases of prostate cancer to the penis and urethra are rare and often represent advanced disease.
  • We describe a case of newly diagnosed prostatic adenocarcinoma with metastases to the corpus spongiosum, cavernosum, and the anterior urethra.
  • Cystoscopy showed a penile urethral tumor and biopsy disclosed metastatic adenocarcinoma of the prostate; the Gleason score was 4 + 4 = 8.
  • [MeSH-major] Adenocarcinoma / pathology. Prostatic Neoplasms / pathology. Urethral Neoplasms / secondary

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Elsevier. Published by Elsevier B.V. All rights reserved.
  • (PMID = 20171591.001).
  • [ISSN] 1728-7731
  • [Journal-full-title] Journal of the Chinese Medical Association : JCMA
  • [ISO-abbreviation] J Chin Med Assoc
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China (Republic : 1949- )
  • [Chemical-registry-number] EC 3.4.21.77 / Prostate-Specific Antigen
  •  go-up   go-down


8. Velazquez EF, Soskin A, Bock A, Codas R, Cai G, Barreto JE, Cubilla AL: Epithelial abnormalities and precancerous lesions of anterior urethra in patients with penile carcinoma: a report of 89 cases. Mod Pathol; 2005 Jul;18(7):917-23
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Epithelial abnormalities and precancerous lesions of anterior urethra in patients with penile carcinoma: a report of 89 cases.
  • Urethral and penile tissues and their neoplasms are considered anatomically and pathogenetically different.
  • Since we observed urethral dysplastic lesions and some similarities between noninvasive and invasive lesions of the anterior urethra and glans, we designed this study to document epithelial urethral abnormalities in patients with penile squamous cell carcinoma.
  • We examined urethral epithelia from 170 penectomies with invasive squamous cell carcinoma finding a variety of primary epithelial abnormalities in 89 cases (52%) and secondary invasion of penile carcinoma to urethra in 42 cases (25%).
  • Urethral squamous intraepithelial lesions of high grade was found in six patients and of low grade in eight cases.
  • Despite the large size of the primary tumors, direct urethral invasion by penile carcinoma was present in only 25% of the cases.
  • The presence of precancerous lesions in urethra of patients with penile carcinoma indicates urethral participation in the pathogenesis of penile cancer.
  • [MeSH-major] Penile Neoplasms / pathology. Precancerous Conditions / pathology. Urethra / pathology. Urethral Neoplasms / pathology
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Carcinoma, Squamous Cell / pathology. Epithelium / abnormalities. Humans. Hyperplasia. Keratosis / pathology. Lichen Sclerosus et Atrophicus / pathology. Male. Metaplasia. Middle Aged. Neoplasm Invasiveness

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15920559.001).
  • [ISSN] 0893-3952
  • [Journal-full-title] Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
  • [ISO-abbreviation] Mod. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


9. Shakespeare D, Mitchell DM, Carey BM, Finan P, Henry AM, Ash D, Bottomley DM, Al-Qaisieh B: Recto-urethral fistula following brachytherapy for localized prostate cancer. Colorectal Dis; 2007 May;9(4):328-31
MedlinePlus Health Information. consumer health - Urethral Disorders.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Recto-urethral fistula following brachytherapy for localized prostate cancer.
  • OBJECTIVE: The use of prostate brachytherapy (BT) in the management of prostate cancer is increasing.
  • One such complication is recto-urethral fistula (RUF).
  • RESULTS: Recto-urethral fistula was identified in three (0.2%) patients, occurring at 19-27 months following BT.
  • Gastrointestinal specialists should not perform biopsy of the anterior rectum in patients who have had BT unless there is a very high clinical suspicion of malignancy.
  • [MeSH-major] Brachytherapy / adverse effects. Prostatic Neoplasms / radiotherapy. Rectal Fistula / etiology. Urethral Diseases / etiology. Urinary Fistula / etiology

  • Genetic Alliance. consumer health - Urethral cancer.
  • Genetic Alliance. consumer health - Prostate cancer.
  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Colorectal Dis. 2008 Jun;10(5):522; author reply 522 [18400038.001]
  • (PMID = 17432984.001).
  • [ISSN] 1462-8910
  • [Journal-full-title] Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
  • [ISO-abbreviation] Colorectal Dis
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


10. Eisenberg ML, Elliott SP, McAninch JW: Management of restenosis after urethral stent placement. J Urol; 2008 Mar;179(3):991-5
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Management of restenosis after urethral stent placement.
  • PURPOSE: We describe our experience with the management of restricture after urethral stent placement, including endoscopic and open surgical treatment.
  • MATERIALS AND METHODS: We surveyed our prospectively collected database for patients with restenosis after urethral stent insertion.
  • RESULTS: Overall we have treated 22 patients with failed urethral stents with a median followup of 30 months (range 1 to 96).
  • All stents were initially placed for urethral stricture management.
  • Stricture etiology included prostate cancer therapy in 9 cases, idiopathic causes in 6, urethral instrumentation in 2, trauma in 2, simple prostatectomy in 2 and gender reassignment/phalloplasty in 1.
  • Ten patients had anterior urethral stricture, 11 had posterior stricture and 1 patient had each type.
  • Ten of the 11 anterior strictures were treated with urethroplasty.
  • Our overall success rate for treatment after stent failure was 67% (8 of 12 cases) for posterior urethral strictures and 82% (9 of 11) for anterior strictures.
  • CONCLUSIONS: Urethral stent failure requires complex intervention.
  • A failed posterior urethral stent can often be managed endoscopically.
  • Conversely we have managed failed anterior urethral stents by urethroplasty.
  • [MeSH-major] Stents. Urethral Stricture / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18206915.001).
  • [ISSN] 1527-3792
  • [Journal-full-title] The Journal of urology
  • [ISO-abbreviation] J. Urol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


11. Eisenberg ML, Elliott SP, McAninch JW: Preservation of lower urinary tract function in posterior urethral stenosis: selection of appropriate patients for urethral stents. J Urol; 2007 Dec;178(6):2456-60; discussion 2460-1
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Preservation of lower urinary tract function in posterior urethral stenosis: selection of appropriate patients for urethral stents.
  • PURPOSE: We describe our experience with urethral stents to manage iatrogenic posterior urethral stenosis.
  • MATERIALS AND METHODS: We surveyed our retrospective database for patients in whom we placed a urethral stent for posterior urethral stricture disease.
  • RESULTS: Overall we placed urethral stents in 13 patients, of whom 12 presented with posterior urethral stenosis and 1 presented with anterior and posterior stricture.
  • The etiology of urethral stricture was prostate cancer therapy in 11 of 13 cases and simple prostatectomy in 2.
  • Urethral stenting was chosen instead of urethral reconstruction largely due to prior radiation for prostate cancer and avoidance of the morbidity of surgery.
  • Eight of 13 patients with a posterior urethral stricture were incontinent, as expected after stent placement.
  • CONCLUSIONS: Urethral stents provide reasonable treatment for patients with posterior urethral stenosis when attempting to preserve lower urinary tract function caused by stricture disease after prostate cancer therapy.
  • Continence can be maintained after posterior urethral stenting in select patients.
  • [MeSH-major] Iatrogenic Disease. Stents. Urethral Stricture / etiology. Urethral Stricture / therapy. Urinary Incontinence / prevention & control

  • MedlinePlus Health Information. consumer health - Urinary Incontinence.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17937962.001).
  • [ISSN] 1527-3792
  • [Journal-full-title] The Journal of urology
  • [ISO-abbreviation] J. Urol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


12. Noorani S, Rao AR, Callaghan PS: Urethral metastasis: an uncommon presentation of a colonic adenocarcinoma. Int Urol Nephrol; 2007;39(3):837-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Urethral metastasis: an uncommon presentation of a colonic adenocarcinoma.
  • INTRODUCTION: Metastases to the urethra are a rare clinical entity.
  • In this report, however we describe a case of urethral metastases from a colonic cancer origin where the urethral lesion was the presenting symptom.
  • CASE REPORT: A 69-year-old woman presented with a swelling at the urethral opening.
  • Per vaginal examination revealed a hard tender lesion situated at the external urethral meatus with contact bleeding.
  • Subsequent investigations revealed that the patient did indeed have a sigmoid adenocarcinoma and underwent chemotherapy with a view to anterior resection and pelvic exenteration.
  • DISCUSSION: Metastases to the urethra are rare.
  • Atypical presentations of urethral lesions should be viewed with suspicion.
  • [MeSH-major] Adenocarcinoma / secondary. Sigmoid Neoplasms / pathology. Urethral Neoplasms / secondary

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17318345.001).
  • [ISSN] 0301-1623
  • [Journal-full-title] International urology and nephrology
  • [ISO-abbreviation] Int Urol Nephrol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Hungary
  •  go-up   go-down


13. Stein JP, Hertz J, Nichols PW: Urethral recurrence in a woman after continent orthotopic urinary diversion for bladder cancer. Urology; 2008 Apr;71(4):755.e1-2
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Urethral recurrence in a woman after continent orthotopic urinary diversion for bladder cancer.
  • We describe a 55-year-old woman with a urethral recurrence of transitional cell carcinoma of her bladder 4 years after she underwent radical cystectomy with negative margins and no evidence of invasion of the bladder neck, anterior vaginal wall, or proximal urethra.
  • This was the first urethral recurrence in an appropriately selected female patient at our institution.
  • [MeSH-major] Carcinoma, Transitional Cell / secondary. Carcinoma, Transitional Cell / surgery. Urethral Neoplasms / secondary. Urinary Bladder Neoplasms / pathology. Urinary Bladder Neoplasms / surgery. Urinary Diversion


14. Jordan GH, Eltahawy EA, Virasoro R: The technique of vessel sparing excision and primary anastomosis for proximal bulbous urethral reconstruction. J Urol; 2007 May;177(5):1799-802
Faculty of 1000. commentaries/discussion - See the articles recommended by F1000Prime's Faculty of more than 8,000 leading experts in Biology and Medicine. (subscription/membership/fee required).

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The technique of vessel sparing excision and primary anastomosis for proximal bulbous urethral reconstruction.
  • PURPOSE: We present a technique not previously described for proximal bulbous or bulbomembranous urethral reconstruction of excision and primary anastomosis.
  • The technique has the potential advantages of preserving the proximal urethral blood supply.
  • MATERIALS AND METHODS: From June 2003 to October 2006, 10 patients underwent vessel sparing urethral reconstruction including 3 after radical prostatectomy, 6 following straddle trauma and 1 potentially with a congenital stricture.
  • A plane was developed between the urethra and the proximal blood supply at the bulbospongiosum, allowing for division of the urethra without dividing the spongy tissue of the corpus spongiosum or the arteries to the bulb.
  • The patients who had undergone radical prostatectomy were either incontinent or were believed to be possibly rendered incontinent after the urethral reconstruction.
  • In patients after radical prostatectomy with proximal anterior urethral or bulbomembranous strictures, preserving the blood supply possibly decreases cuff erosion when undergoing later implantation Many patients (approximately 12% lifetime risk of prostate cancer) will require radical prostatectomy and may later require a sphincter.
  • [MeSH-major] Reconstructive Surgical Procedures / methods. Urethra / innervation. Urethra / surgery. Urethral Stricture / surgery. Urologic Surgical Procedures, Male / methods

  • MedlinePlus Health Information. consumer health - Plastic and Cosmetic Surgery.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Urol. 2007 May;177(5):1609-10 [17437769.001]
  • (PMID = 17437823.001).
  • [ISSN] 0022-5347
  • [Journal-full-title] The Journal of urology
  • [ISO-abbreviation] J. Urol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


15. Green JM, Tang WW, Jensen BW, Orihuela E: Isolated recurrence of ductal prostate cancer to anterior urethra. Urology; 2006 Aug;68(2):428.e13-5
MedlinePlus Health Information. consumer health - Prostate Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Isolated recurrence of ductal prostate cancer to anterior urethra.
  • We report the case of a 74-year-old man with ductal prostate cancer who had originally undergone radiotherapy but developed metastases to the anterior urethral mucosa.
  • [MeSH-major] Prostatic Neoplasms / pathology. Urethral Neoplasms / secondary

  • Genetic Alliance. consumer health - Prostate cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16904476.001).
  • [ISSN] 1527-9995
  • [Journal-full-title] Urology
  • [ISO-abbreviation] Urology
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


16. Nguyen L, Jhaveri J, Tewari A: Surgical technique to overcome anatomical shortcoming: balancing post-prostatectomy continence outcomes of urethral sphincter lengths on preoperative magnetic resonance imaging. J Urol; 2008 May;179(5):1907-11
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Surgical technique to overcome anatomical shortcoming: balancing post-prostatectomy continence outcomes of urethral sphincter lengths on preoperative magnetic resonance imaging.
  • PURPOSE: Shorter urethral sphincter length on preoperative endorectal magnetic resonance imaging has been associated with an increased risk of postoperative urinary incontinence as well as longer time to achieve continence.
  • We determined that our techniques of anatomical reconstruction for restoring the continence mechanism could markedly improve continence outcomes, especially in patients with a shorter urethral sphincter.
  • The continence rate in the shorter sphincter group (less than 14 mm) was 47% for the control technique, 81% for anterior reconstruction and 90% for total reconstruction.
  • The continence rate in the longer sphincter group (more than 14 mm) was 80% for the control technique and 83% for anterior reconstruction, while it approached 99% for total reconstruction.
  • The significance disappeared for anterior reconstruction (7.4 vs 6.2 weeks, p = 0.27) and total reconstruction (3.6 vs 2.7 weeks, p = 0.13).
  • CONCLUSIONS: The results of this study are encouraging for patients with a short urethral sphincter who are considering radical prostatectomy.
  • [MeSH-major] Magnetic Resonance Imaging. Prostatectomy / adverse effects. Urethra / pathology. Urethra / surgery. Urinary Incontinence / prevention & control

  • MedlinePlus Health Information. consumer health - MRI Scans.
  • MedlinePlus Health Information. consumer health - Urinary Incontinence.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18353395.001).
  • [ISSN] 1527-3792
  • [Journal-full-title] The Journal of urology
  • [ISO-abbreviation] J. Urol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


17. Iborra F, Rigaud J, Bastide C, Mottet N, les membres du sous-comité organes génitaux externes du comité de cancérologie de l'AFU: [Treatment of primary urethral carcinoma. Guidelines from the French Urological Association. Cancer committee]. Prog Urol; 2009 Mar;19(3):170-5
Genetic Alliance. consumer health - Urethral cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Treatment of primary urethral carcinoma. Guidelines from the French Urological Association. Cancer committee].
  • For anterior T1 or 2 lesions, surgery is the most often used modality.
  • [MeSH-major] Carcinoma / therapy. Urethral Neoplasms / therapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19268254.001).
  • [ISSN] 1166-7087
  • [Journal-full-title] Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie
  • [ISO-abbreviation] Prog. Urol.
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Practice Guideline; Review
  • [Publication-country] France
  • [Chemical-registry-number] 0 / BCG Vaccine
  • [Number-of-references] 28
  •  go-up   go-down


18. Abou-Elela A: Outcome of anterior vaginal wall sparing during female radical cystectomy with orthotopic urinary diversion. Eur J Surg Oncol; 2008 Jan;34(1):115-21

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Outcome of anterior vaginal wall sparing during female radical cystectomy with orthotopic urinary diversion.
  • Pathological specimens revealed a negative posterior bladder wall and urethral margins in all cases.
  • CONCLUSIONS: With strict selection criteria, anterior vaginal wall preservation in female radical cystectomy with orthotopic neobladder substitution is technically feasible, maintains vaginal length and support, has excellent functional results, acceptable complication rate and can achieve negative margins.
  • Long-term evaluation is needed for better assessment of the impact on functional outcomes and cancer control.
  • [MeSH-minor] Adult. Aged. Colonic Pouches. Female. Humans. Middle Aged. Treatment Outcome. Urethra / surgery. Urinary Bladder / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [RetractionIn] Eur J Surg Oncol. 2009 Apr;35(4):448 [19266631.001]
  • (PMID = 17951022.001).
  • [ISSN] 1532-2157
  • [Journal-full-title] European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
  • [ISO-abbreviation] Eur J Surg Oncol
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article; Retracted Publication
  • [Publication-country] England
  •  go-up   go-down


19. Prada PJ, Fernández J, Martinez AA, de la Rúa A, Gonzalez JM, Fernandez JM, Juan G: Transperineal injection of hyaluronic acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity modulated brachytherapy or EBRT for prostate cancer patients. Int J Radiat Oncol Biol Phys; 2007 Sep 1;69(1):95-102
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Transperineal injection of hyaluronic acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity modulated brachytherapy or EBRT for prostate cancer patients.
  • PURPOSE: Rectal toxicity remains a serious complication affecting quality of life for prostate cancer patients treated with radiotherapy.
  • We began an investigational trial injecting hyaluronic acid (HA) in the perirectal fat to increase the distance between the prostate and the anterior rectal wall.
  • METHODS AND MATERIALS: This is a trial of external beam radiation therapy with HDR brachytherapy boosts in prostate cancer.
  • During the two high-dose-rate (HDR) fractions, thermoluminescent dosimeter dosimeters were placed in the urethra and in the rectum.
  • Urethral and rectal HDR doses were calculated and measured.
  • The median measured rectal dose, when normalized to the median urethral dose, demonstrated a decrease in dose from 47.1% to 39.2% (p < 0.001) with or without injection.

  • Genetic Alliance. consumer health - Rectal Cancer.
  • Genetic Alliance. consumer health - Prostate cancer.
  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • Hazardous Substances Data Bank. HYALURONIC ACID .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):316-7 [18406899.001]
  • (PMID = 17707267.001).
  • [ISSN] 0360-3016
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Radiation-Protective Agents; 9004-61-9 / Hyaluronic Acid
  •  go-up   go-down


20. Stein JP, Penson DF, Wu SD, Skinner DG: Pathological guidelines for orthotopic urinary diversion in women with bladder cancer: a review of the literature. J Urol; 2007 Sep;178(3 Pt 1):756-60
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pathological guidelines for orthotopic urinary diversion in women with bladder cancer: a review of the literature.
  • PURPOSE: Before the early 1990s total urethrectomy at radical cystectomy for bladder cancer in women was considered the standard of care.
  • As our understanding of the natural history of urethral urothelial carcinoma in women has improved, neobladders have been increasingly created in carefully selected women with bladder cancer.
  • We reviewed the literature regarding the incidence of urethral involvement, the risk factors for urethral involvement and the incidence of urethral recurrence in women undergoing orthotopic urinary diversion for bladder cancer.
  • MATERIALS AND METHODS: A comprehensive literature review was performed regarding the natural history of urethral tumor involvement by urothelial carcinoma, risk factors and the incidence of urethral recurrence following radical cystectomy and orthotopic diversion in women with bladder cancer.
  • RESULTS: Urethral tumor involvement occurs in approximately 12% of female patients with bladder cancer undergoing radical cystectomy for high grade, invasive urothelial carcinoma.
  • Preoperative involvement of the bladder neck or anterior vaginal wall with urothelial carcinoma is an important risk factor for urethral tumor involvement.
  • Intraoperative frozen section analysis of the proximal urethra is an appropriate and reliable method of identifying female candidates for orthotopic diversion.
  • The rate of secondary tumor recurrence in the retained urethra of women following radical cystectomy and orthotopic urinary diversion is low but the condition requires long-term followup.
  • CONCLUSIONS: Orthotopic urinary diversion can be performed safely in appropriately selected women with bladder cancer.
  • Excellent oncological outcomes can be expected with a minimal risk of urethral recurrence.
  • Preoperative bladder neck involvement is an important risk factor for urethral involvement but not an absolute contraindication to orthotopic diversion should intraoperative frozen section of the proximal urethra be without evidence of malignancy.
  • [MeSH-major] Urethral Neoplasms / secondary. Urinary Bladder Neoplasms / surgery. Urinary Diversion. Urinary Reservoirs, Continent
  • [MeSH-minor] Cystectomy. Female. Humans. Neoplasm Recurrence, Local. Neoplasms, Multiple Primary / pathology. Neoplasms, Multiple Primary / surgery

  • Genetic Alliance. consumer health - Bladder cancer.
  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17631333.001).
  • [ISSN] 0022-5347
  • [Journal-full-title] The Journal of urology
  • [ISO-abbreviation] J. Urol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 33
  •  go-up   go-down


21. Ungar L, Palfalvi L, Novak Z: Primary pelvic exenteration in cervical cancer patients. Gynecol Oncol; 2008 Nov;111(2 Suppl):S9-12
MedlinePlus Health Information. consumer health - Cervical Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary pelvic exenteration in cervical cancer patients.
  • Despite the reports of a number of leading institutions concerning the use of primary exenteration, there are differences in regard to definition, indications, and interpretation of results of this treatment approach to cervical cancer.
  • In this paper we present our own experience with 41 cervical cancer patients treated with primary exenteration at St. Stephen Hospital Budapest.
  • Between January 1993 and June 2006, 2540 invasive cervical cancer patients were seen at the gynecologic oncology service of the St. Stephens Hospital Budapest.
  • Exenteration was the primary treatment in 41 (25%) of 166 completed exenterations; these 41 cases included 2 cases of supralevator total exenteration, 9 cases of supralevator anterior exenteration, and 30 cases of partial supralevator anterior exenteration.
  • Urethral function was restored in 9 out of 11 supralevator exenteration cases with the Budapest pouch bladder replacement technique.
  • A 50% survival rate of a select group of stage IVA cervical cancer patients treated with primary exenteration can be considered significant, but cannot be considered superior to that of chemoradiation therapy.
  • Low rectal anastomosis and orthotopic bladder replacement with a relative low risk of fistula formation in non-irradiated patients constitute a strong quality of life argument in favor of primary exenteration in a select group of stage IVA cervical cancer patients.

  • Genetic Alliance. consumer health - Cervical cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18775558.001).
  • [ISSN] 1095-6859
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


22. Yoshinaga A, Hayashi T, Ishii N, Ohno R, Terao T, Kamata S, Watanabe T, Yamada T: [Vesicorectal fistula caused by pelvic metastasis of penile cancer: a case report]. Hinyokika Kiyo; 2005 Jan;51(1):53-5

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Vesicorectal fistula caused by pelvic metastasis of penile cancer: a case report].
  • Tumor biopsy revealed squamous cell carcinoma.
  • Although he was given radiation therapy and subcutaneous injection therapy of bleomycin, viable cancer cells remained.
  • Local recurrence with a cauliflower-like tumor occurred five years after the chemotherapy.
  • Computerized tomography of pelvis demonstrated a mass 3 cm in diameter in the anterior portion of anal and cystogram demonstrated a vesicorectal fistula.
  • Then we inserted a urethral catheter, which resulted in obstruction of fistula by its balloon, and we made a cystostomy for securing urinary tract.
  • His quality of life was improved, but his general condition became worse gradually and he died of cancer.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15732344.001).
  • [ISSN] 0018-1994
  • [Journal-full-title] Hinyokika kiyo. Acta urologica Japonica
  • [ISO-abbreviation] Hinyokika Kiyo
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


23. Miyake H, Fujimoto H, Komiyama M, Fujisawa M: Development of "extended radical retropubic prostatectomy": a surgical technique for improving margin positive rates in prostate cancer. Eur J Surg Oncol; 2010 Mar;36(3):281-6
MedlinePlus Health Information. consumer health - Prostate Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Development of "extended radical retropubic prostatectomy": a surgical technique for improving margin positive rates in prostate cancer.
  • AIMS: The objective of this study was to introduce a surgical approach called "extended radical retropubic prostatectomy (ERRP)" developed to reduce positive surgical margin rates in prostate cancer.
  • METHODS: Modified surgical procedures in ERRP included apical dissection (division of the dorsal venous complex far distal to the prostatic urethral junction), excision of the bilateral neurovascular bundles (wide resection of structure between the exterior of the urethra and the rectal surface, which contains the neurovascular bundle), perirectal dissection (complete resection of perirectal tissue by dissecting the anterior rectal surface until the muscle layer of the rectum was encountered) and seminal vesicle excision (dissection that leaves seminal vesicles protected by Denonvilliers' fascia with the surrounding fatty and fascial coverings without pulling seminal vesicles from the prostate).
  • [MeSH-minor] Aged. Follow-Up Studies. Humans. Male. Middle Aged. Neoplasm Recurrence, Local / blood. Neoplasm Recurrence, Local / prevention & control. Neoplasm Staging. Prostate-Specific Antigen / blood. Treatment Outcome

  • Genetic Alliance. consumer health - Prostate cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2009 Elsevier Ltd. All rights reserved.
  • (PMID = 19897336.001).
  • [ISSN] 1532-2157
  • [Journal-full-title] European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
  • [ISO-abbreviation] Eur J Surg Oncol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] EC 3.4.21.77 / Prostate-Specific Antigen
  •  go-up   go-down


24. Ji H, Pan J, Shen W, Wu X, Zhang J, Fang Q, Li X, Yan J, Li X, Song B, Chen Z: Identification and management of emptying failure in male patients with orthotopic neobladders after radical cystectomy for bladder cancer. Urology; 2010 Sep;76(3):644-8
MedlinePlus Health Information. consumer health - Bladder Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Identification and management of emptying failure in male patients with orthotopic neobladders after radical cystectomy for bladder cancer.
  • OBJECTIVE: To treat neobladder emptying failure after radical cystectomy in patients with bladder cancer.
  • Emptying failure was a result of mechanical obstruction in 25 (10.8%) patients; obstructions were caused by strictures of the neobladder-urethral anastomosis (13 cases, 5.6%), anterior urethral strictures (3 cases, 1.2%), obstructive mucosal valves (2 cases, 0.9%), primary cystolithiasis (1 case, 0.4%), mucus plugs (2 cases, 0.9%), urethral tumor recurrence (2 cases, 0.9%), and pelvic tumor recurrence (2 cases, 0.9%).
  • Two patients were found with a narrower posterior urethral angle.

  • Genetic Alliance. consumer health - Bladder cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Inc. All rights reserved.
  • (PMID = 20573379.001).
  • [ISSN] 1527-9995
  • [Journal-full-title] Urology
  • [ISO-abbreviation] Urology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


25. Wu SD, Simma-Chang V, Stein JP: Pathologic guidelines for orthotopic urinary diversion in women with bladder cancer: a review of the literature. Rev Urol; 2006;8(2):54-60

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pathologic guidelines for orthotopic urinary diversion in women with bladder cancer: a review of the literature.
  • Orthotopic lower urinary tract reconstruction to the native intact urethra following radical cystectomy for bladder cancer was slower to gain clinical acceptance for women than for men.
  • Until the 1990s, little was known about the natural history of urethral involvement by urothelial carcinoma in women with primary bladder cancer.
  • The increasing availability of pathologic data to define the incidence of and risks for urethral involvement in women sparked an increasing interest in orthotopic diversion in female patients.
  • Preoperative involvement of the bladder neck is a significant risk factor for secondary tumor of the urethra, but is not an absolute contraindication, as long as full-thickness, intraoperative frozen-section analysis demonstrates no tumor involvement of the proximal urethra.
  • Although less common, anterior vaginal wall tumor involvement may be a significant risk factor for urethral tumor involvement.
  • Other pathologic parameters, including tumor multifocality, carcinoma in situ of the bladder, and tumor grade and stage, do not seem to be absolute contraindications.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Urol. 2000 Nov;164(5):1646 [11025726.001]
  • [Cites] Urology. 1998 Jun;51(6):951-5 [9609632.001]
  • [Cites] Cancer. 2001 Oct 1;92(7):1864-71 [11745259.001]
  • [Cites] J Urol. 1976 Jan;115(1):56-60 [1246114.001]
  • [Cites] Crit Rev Oncol Hematol. 2003 Aug;47(2):147-54 [12900008.001]
  • [Cites] Br J Urol. 1956 Mar;28(1):3-13 [13304293.001]
  • [Cites] J Urol. 2004 Jan;171(1):275-8 [14665893.001]
  • [Cites] J Urol. 2004 Apr;171(4):1585-8 [15017226.001]
  • [Cites] J Urol. 2004 Oct;172(4 Pt 1):1338-41 [15371836.001]
  • [Cites] CA Cancer J Clin. 2005 Jan-Feb;55(1):10-30 [15661684.001]
  • [Cites] Cancer. 1990 Mar 1;65(5):1237-41 [2302672.001]
  • [Cites] Br J Urol. 1985 Oct;57(5):535-41 [4063735.001]
  • [Cites] Br J Urol. 1971 Apr;43(2):201-5 [5103907.001]
  • [Cites] J Urol. 1978 Jan;119(1):80-1 [621821.001]
  • [Cites] J Urol. 1995 Oct;154(4):1329-33 [7658531.001]
  • [Cites] J Urol. 1995 Mar;153(3 Pt 2):950-5 [7853581.001]
  • [Cites] J Urol. 1994 Nov;152(5 Pt 1):1438-42 [7933179.001]
  • [Cites] J Urol. 1996 Nov;156(5):1615-9 [8863551.001]
  • [Cites] Urology. 1997 Oct;50(4):537-41 [9338728.001]
  • [CommentIn] Eur Urol. 2007 Mar;51(3):849-50 [17421061.001]
  • (PMID = 17021627.001).
  • [ISSN] 1523-6161
  • [Journal-full-title] Reviews in urology
  • [ISO-abbreviation] Rev Urol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC1578541
  •  go-up   go-down


26. Kanzaki M, Seki Y, Maeda M, Miyoshi S: [A fatal case of meningeal carcinomatosis in a stage IV rectal cancer patient who had long time survival by multi- line chemotherapy]. Gan To Kagaku Ryoho; 2009 Mar;36(3):509-11
MedlinePlus Health Information. consumer health - Cancer Chemotherapy.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A fatal case of meningeal carcinomatosis in a stage IV rectal cancer patient who had long time survival by multi- line chemotherapy].
  • A 65-year-old man was referred with Stage IV rectal cancer with lung and liver metastasis.
  • He had done low anterior resection.
  • One month after operation, he was administered anti-cancer drugs of FOLFOX4 protocol.
  • He was treated by urethral stenting, and FOLFOX protocol was re-started.
  • [MeSH-minor] Aged. Fatal Outcome. Humans. Male. Neoplasm Staging. Time Factors. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Rectal Cancer.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19295283.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Antineoplastic Agents
  •  go-up   go-down


27. Sánchez-Ortiz R, Huang SF, Tamboli P, Prieto VG, Hester G, Pettaway CA: Melanoma of the penis, scrotum and male urethra: a 40-year single institution experience. J Urol; 2005 Jun;173(6):1958-65
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Melanoma of the penis, scrotum and male urethra: a 40-year single institution experience.
  • We describe our experience with 10 patients with penile or urethral involvement.
  • RESULTS: Of 10 patients with penile or urethral melanoma 1997 American Joint Committee on Cancer melanoma pathological stage was T1 (depth less than 0.75 mm) in 4, T2 (0.75 to 1.5 mm) in 3 and T3 (1.51 to 4 mm) in 3.
  • CONCLUSIONS: Partial penectomy or WLE provided effective local control for low stage penile or urethral melanomas and all scrotal lesions.
  • Prophylactic modified inguinal lymphadenectomy should be considered in select patients with penile, scrotal and anterior urethral melanoma.
  • [MeSH-major] Genital Neoplasms, Male / surgery. Melanoma / surgery. Penile Neoplasms / surgery. Scrotum / surgery. Urethral Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Chemotherapy, Adjuvant. Combined Modality Therapy. Disease Progression. Disease-Free Survival. Humans. Lymphatic Metastasis / pathology. Male. Middle Aged. Neoplasm Recurrence, Local / drug therapy. Neoplasm Recurrence, Local / mortality. Neoplasm Recurrence, Local / pathology. Neoplasm Recurrence, Local / surgery. Neoplasm Staging. Retrospective Studies. Survival Rate

  • MedlinePlus Health Information. consumer health - Melanoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Urol. 2006 Apr;175(4):1574-5; author reply 1575-6 [16516049.001]
  • (PMID = 15879790.001).
  • [ISSN] 0022-5347
  • [Journal-full-title] The Journal of urology
  • [ISO-abbreviation] J. Urol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


28. Noguchi M, Shimada A, Nakashima O, Kojiro M, Matsuoka K: Urodynamic evaluation of a suspension technique for rapid recovery of continence after radical retropubic prostatectomy. Int J Urol; 2006 Apr;13(4):373-8
MedlinePlus Health Information. consumer health - Urinary Incontinence.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: A total of 45 consecutive patients (mean age 67.6 years) who had undergone radical retropubic prostatectomy for localized prostate cancer were evaluated with multichannel urodynamics including the maximal urethral pressure (MUP), functional urethral length (FUL), maximal cystometric capacity (MCC) and abdominal leak point pressure (ALPP) at base line, 1 week, 1 month, and 3 months postoperatively.
  • The suspension of vesicourethral anastomosis preserving anterior attachments of puboprostatic ligaments to pubic bone was performed in 33 patients.
  • CONCLUSIONS: These observations suggest that preserving anterior attachments of puboprostatic ligaments to pubic bone and fixation of urethral hyper-mobility by the suspension of vesicourethral anastomosis promotes rapid recovery of urinary continence after radical retropubic prostatectomy.

  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16734853.001).
  • [ISSN] 0919-8172
  • [Journal-full-title] International journal of urology : official journal of the Japanese Urological Association
  • [ISO-abbreviation] Int. J. Urol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


29. Hamano S, Nakatsu H, Suzuki N, Murakami S: Usefulness of tonsil forceps in radical retropubic prostatectomy. Int J Urol; 2006 Jun;13(6):854-6
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The presence of positive surgical margins after radical retropubic prostatectomy (RRP) for prostate cancer leads to an increased risk of progression and reduces disease free survival.
  • The urethra usually enters the prostate slightly anterior and proximal to the prostatic apex.
  • After dividing the dorsal vessels and separating neurovascular bundles (NVB) from the prostatic urethral junction using scissors, the operator dissects around the urethra just below the apex to avoid incision into the apex and injury of the NVB and sphincter mechanism.
  • Its special curved shape with an angle of 105 degrees and short tip should make it much easier to isolate the urethra just below the apex from the surrounding tissue.
  • [MeSH-minor] Humans. Male. Prostate / surgery. Surgical Instruments. Urethra / surgery

  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16834683.001).
  • [ISSN] 0919-8172
  • [Journal-full-title] International journal of urology : official journal of the Japanese Urological Association
  • [ISO-abbreviation] Int. J. Urol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


30. Showalter TN, Nawaz AO, Xiao Y, Galvin JM, Valicenti RK: A cone beam CT-Based Study for Clinical Target Definition Using Pelvic Anatomy During Postprostatectomy Radiotherapy. Int J Radiat Oncol Biol Phys; 2008 Feb 1;70(2):431-6
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS AND MATERIALS: The pelvic anatomy of 10 prostate cancer patients undergoing post-RP radiation therapy (RT) to 68.4 Gy was studied using CBCT images obtained immediately before treatment.
  • Contoured bladder and rectal volumes on CBCT images were compared with planning CT (CT(ref)) volumes from seminal vesicle stump (SVS) to bladder-urethral junction.
  • Anterior and posterior planning target volume margins were calculated using ICRU report 71 guidelines, accounting for systematic and random error based on bladder and rectal motion, respectively.
  • Relative to CT(ref), mean posterior bladder wall position was anterior by 0.1 to 1.5 mm, and mean anterior rectum wall position was posterior by 1.6 to 2.7 mm.
  • Calculated anterior margin as derived from bladder motion ranged from 5.9 to 7.1 mm.

  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17869021.001).
  • [ISSN] 0360-3016
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


31. Chirica M, Parc Y, Tiret E, Dehni N, McNamara D, Parc R: Coloanal sleeve anastomosis (Soave procedure): the ultimate treatment option for complex rectourinary fistulas. Dis Colon Rectum; 2006 Sep;49(9):1379-83

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Four fistulas were the result of radical prostatectomy and four followed anterior resection for rectal cancer after radiochemotherapy.
  • The location of the fistulas was bladder (n = 5) and urethra (n = 3).
  • [MeSH-minor] Adult. Aged. Anastomosis, Surgical. Humans. Male. Middle Aged. Salvage Therapy. Urethral Diseases / etiology. Urethral Diseases / surgery. Urinary Bladder Fistula / etiology. Urinary Bladder Fistula / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16819570.001).
  • [ISSN] 0012-3706
  • [Journal-full-title] Diseases of the colon and rectum
  • [ISO-abbreviation] Dis. Colon Rectum
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


32. Lim MC, Lee SM, Lee J, Choi HJ, Lee S, Huh CY, Park SY: Endometrioid adenocarcinoma in urethrovaginal septum: a diagnostic pitfall. J Korean Med Sci; 2009 Feb;24(1):162-5
MedlinePlus Health Information. consumer health - Vaginal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A pinpoint ulceration at slightly elevated anterior vaginal wall was found and biopsy revealed endometrioid adenocarcinoma.
  • She has undergone anterior pelvic exenteration, pelvic lymph node dissection, and urostomy with ileal conduit.
  • Tumor at urethrovaginal septum was difficult to be detected till growing to be bulky, because of vaginal axis, misunderstanding of the tumor as symphysis pubis, no definitive symptom, and its rarity.
  • Understanding normal functional anatomy and meticulous physical examination are essential to detect this rare tumor in the urethrovaginal septum.
  • [MeSH-major] Carcinoma, Endometrioid / diagnosis. Endometrial Neoplasms / diagnosis. Urethral Neoplasms / diagnosis. Vaginal Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Obstet Gynecol. 1970 Aug;36(2):251-6 [5428492.001]
  • [Cites] Gynecol Oncol. 1984 Jan;17(1):58-63 [6420243.001]
  • [Cites] Hinyokika Kiyo. 1988 Apr;34(4):696-700 [3041781.001]
  • [Cites] Obstet Gynecol. 2006 Sep;108(3 Pt 2):753-5 [17018491.001]
  • [Cites] Eur J Gynaecol Oncol. 1998;19(1):39-41 [9476057.001]
  • [Cites] Jpn J Clin Oncol. 2005 Mar;35(3):154-7 [15741306.001]
  • [Cites] Gynecol Oncol. 1989 Aug;34(2):232-6 [2666285.001]
  • (PMID = 19270832.001).
  • [ISSN] 1598-6357
  • [Journal-full-title] Journal of Korean medical science
  • [ISO-abbreviation] J. Korean Med. Sci.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Korea (South)
  • [Other-IDs] NLM/ PMC2650998
  • [Keywords] NOTNLM ; Carcinoma, Endometrioid / Urethrovaginal Septum
  •  go-up   go-down


33. Seifert AW, Harfe BD, Cohn MJ: Cell lineage analysis demonstrates an endodermal origin of the distal urethra and perineum. Dev Biol; 2008 Jun 1;318(1):143-52
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cell lineage analysis demonstrates an endodermal origin of the distal urethra and perineum.
  • The penile urethra has been reported to develop from two cell populations, with the proximal urethra developing from endoderm and the distal urethra forming from an apical ectodermal invagination, however this has never been tested by direct analysis of cell lineage.
  • We report that the entire urethra, including the distal (glandar) region, is derived from endoderm.
  • Cloacal endoderm also gives rise to the epithelial linings of the bladder, rectum and anterior region of the anus.
  • In addition, we fate mapped genital tubercle ectoderm and show that it makes no detectable contribution to the urethra.
  • In males, formation of the urethral tube involves septation of the urethral plate by continued growth of the urorectal septum.
  • Analysis of cell lineage following disruption of androgen signaling revealed that the urethral plate of flutamide-treated males does not undergo this septation event.
  • Instead, urethral plate cells persist to the ventral margin of the tubercle, mimicking the pattern seen in females.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nat Rev Genet. 2003 Jun;4(6):478-82 [12776217.001]
  • [Cites] Am J Pathol. 2002 Oct;161(4):1111-7 [12368184.001]
  • [Cites] Differentiation. 2003 Oct;71(8):445-60 [14641326.001]
  • [Cites] Br J Plast Surg. 2004 Jan;57(1):27-36 [14672675.001]
  • [Cites] Dev Biol. 2004 Jan 1;265(1):61-74 [14697353.001]
  • [Cites] Br J Plast Surg. 2004 Apr;57(3):203-14 [15006521.001]
  • [Cites] Br J Plast Surg. 2004 Mar;57(2):112-21 [15037165.001]
  • [Cites] Dev Biol. 2004 Jul 15;271(2):272-90 [15223334.001]
  • [Cites] Anat Rec A Discov Mol Cell Evol Biol. 2004 Aug;279(2):761-7 [15278947.001]
  • [Cites] Cell. 2004 Aug 20;118(4):517-28 [15315763.001]
  • [Cites] Nature. 1970 Sep 19;227(5264):1217-9 [5452809.001]
  • [Cites] J Anat. 1954 Jul;88(3):413-25 [13192029.001]
  • [Cites] Adv Anat Embryol Cell Biol. 2005;177:1-131 [15615037.001]
  • [Cites] Development. 2005 May;132(10):2441-50 [15843416.001]
  • [Cites] Dev Dyn. 2006 Jul;235(7):1738-52 [16598715.001]
  • [Cites] J Urol. 2006 Oct;176(4 Pt 2):1883-8 [16945680.001]
  • [Cites] Development. 2006 Dec;133(23):4783-92 [17079275.001]
  • [Cites] J Pediatr Surg. 2000 Feb;35(2):227-30; discussion 230-1 [10693670.001]
  • [Cites] Cell. 1974 Sep;3(1):59-64 [4369847.001]
  • [Cites] J Embryol Exp Morphol. 1986 Mar;92:133-43 [3723059.001]
  • [Cites] Cell. 1993 Dec 31;75(7):1417-30 [7916661.001]
  • [Cites] Mech Dev. 1994 Dec;48(3):187-97 [7893602.001]
  • [Cites] Development. 1995 Oct;121(10):3163-74 [7588051.001]
  • [Cites] J Pediatr Surg. 1995 Aug;30(8):1143-7 [7472968.001]
  • [Cites] Dev Biol. 1995 Nov;172(1):126-38 [7589793.001]
  • [Cites] Development. 1997 Dec;124(23):4781-91 [9428414.001]
  • [Cites] Teratology. 1998 Feb;57(2):70-8 [9562679.001]
  • [Cites] Nat Genet. 1999 Jan;21(1):70-1 [9916792.001]
  • [Cites] Differentiation. 1999 Jan;64(2):115-22 [10234808.001]
  • [Cites] Nat Genet. 2000 May;25(1):83-6 [10802662.001]
  • [Cites] Am J Pathol. 2001 Aug;159(2):765-74 [11485934.001]
  • [Cites] Cell Tissue Res. 2001 Sep;305(3):379-87 [11572091.001]
  • [Cites] Endocrinology. 2001 Nov;142(11):4652-62 [11606430.001]
  • [Cites] Development. 2001 Nov;128(21):4241-50 [11684660.001]
  • [Cites] BJU Int. 2002 May;89(7):726-32 [11966633.001]
  • [Cites] BJU Int. 2002 May;89(7):733-9 [11966634.001]
  • [Cites] Dev Biol. 2002 Jul 1;247(1):26-46 [12074550.001]
  • [Cites] Development. 2003 Dec;130(25):6209-20 [14602679.001]
  • (PMID = 18439576.001).
  • [ISSN] 1095-564X
  • [Journal-full-title] Developmental biology
  • [ISO-abbreviation] Dev. Biol.
  • [Language] ENG
  • [Grant] United States / NICHD NIH HHS / HD / HD054554-01; United States / NICHD NIH HHS / HD / R01 HD054554; United States / NICHD NIH HHS / HD / 1R01 HD054554-01; United States / NICHD NIH HHS / HD / R01 HD054554-01
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Androgen Antagonists; 76W6J0943E / Flutamide
  • [Other-IDs] NLM/ NIHMS53182; NLM/ PMC3047571
  •  go-up   go-down


34. Porzionato A, Macchi V, Gardi M, Parenti A, De Caro R: Histotopographic study of the rectourethralis muscle. Clin Anat; 2005 Oct;18(7):510-7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Radical perineal prostatectomy, relative to retropubic prostatectomy, has become an increasingly used surgical technique for prostate cancer, following advances in laparoscopic methods for pelvic lymph node dissection.
  • In the majority of adult and infant cases, attachment of muscle fibers into the anterior wall of the anal canal was also observed.
  • Anteriorly, the mean (+/-SD) distance between the RUM and the membranous urethra was 5.3 (+/-1.25) mm in adults and 1.0 (+/-0.41) mm in infants.
  • Location of RUM in the prerectal space and the absence of urethral attachment makes the original name of this muscle, "prerectal," by Henle, more correct.
  • [MeSH-major] Muscle, Smooth / anatomy & histology. Pelvic Floor / anatomy & histology. Perineum / anatomy & histology. Rectum / anatomy & histology. Urethra / anatomy & histology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2005 Wiley-Liss, Inc.
  • (PMID = 16121390.001).
  • [ISSN] 0897-3806
  • [Journal-full-title] Clinical anatomy (New York, N.Y.)
  • [ISO-abbreviation] Clin Anat
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


35. Liebrich C, Reinecke-Lüthge A, Kühnle H, Petry KU: [Squamous cell carcinoma in neovagina at Mayer-Rokitansky-Küster-Hauser-syndrome]. Zentralbl Gynakol; 2006 Oct;128(5):271-4
MedlinePlus Health Information. consumer health - Vaginal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Carcinoma of the vagina is a rare entity of cancer, also a primary carcinoma of the neovagina in patients with vaginal agenesia is of rare occurrence.
  • Operative treatment consisted of anterior exenteration with construction of a modified Mainz-1-pouch.
  • Microscopic findings showed a G2-differentiated invasive squamous cell carcinoma of the neovagina at stage FIGO III with an infiltration of urethra and the bladder neck.
  • The tumor could be resected completely, no infestation of lymph nodes was observed.
  • CONCLUSIONS: Female patients with a neovagina require a regular gynaecologic examination in order not to survey a malignant transformation although a malignoma in neovagina is rare.
  • [MeSH-minor] Cell Transformation, Neoplastic. Female. Humans. Middle Aged. Neoplasm Staging. Urethral Neoplasms / pathology


36. Morlino A, Tramutola G, Rossi MT, Scutari F: [Colo-anal anastomosis. Our experience]. G Chir; 2009 Mar;30(3):100-6

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The aim of study is to report the results of our experience about ultra-low rectum carcinomas treated with anterior resection and colo-anal anastomosis.
  • The surgery still represents the treatment of choice for the cancer of the rectum.
  • The problems concern the conservation of the sphincter functions (anal and urethral), and sexual function and the reduction of the locoregional recurrences.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19351460.001).
  • [ISSN] 0391-9005
  • [Journal-full-title] Il Giornale di chirurgia
  • [ISO-abbreviation] G Chir
  • [Language] ita
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


37. Yoshio Y, Ishii K, Arase S, Hori Y, Nishikawa K, Soga N, Kise H, Arima K, Sugimura Y: Effect of transforming growth factor α overexpression on urogenital organ development in mouse. Differentiation; 2010 Sep-Oct;80(2-3):82-8
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • However, whether TGFα induces cancer by itself is unknown in urogenital organs.
  • Prostates were separated into anterior prostate (AP), dorsolateral prostate (DLP), and ventral prostate (VP).
  • Neither tumor formation nor epithelial hyperplasia was observed in the TGFα TG mouse urogenital organs that we have investigated.
  • Ki67 labeling index was increased significantly in the TGFα TG mouse urethral epithelium, whereas neither epithelial hyperplasia nor hypertrophy was observed.
  • In conclusion, our results suggest that TGFα overexpression in mouse urogenital organs alone may not be responsible for tumor formation and epithelial hyperplasia, but is involved in bladder outlet obstruction.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 International Society of Differentiation. Published by Elsevier B.V. All rights reserved.
  • (PMID = 20638776.001).
  • [ISSN] 1432-0436
  • [Journal-full-title] Differentiation; research in biological diversity
  • [ISO-abbreviation] Differentiation
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / DNA Primers; 0 / Transforming Growth Factor alpha
  •  go-up   go-down


38. Kaiho Y, Nakagawa H, Saito H, Ito A, Ishidoya S, Saito S, Arai Y: Nerves at the ventral prostatic capsule contribute to erectile function: initial electrophysiological assessment in humans. Eur Urol; 2009 Jan;55(1):148-54
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • DESIGN, SETTING, AND PARTICIPANTS: The circumference of the prostate capsule was electrically stimulated during radical retropubic prostatectomy (RRP) in 12 patients with clinically localized prostate cancer (PCa).
  • MEASUREMENTS: Changes in pressure at the middle of the urethra were measured using an inserted balloon catheter to detect increases in cavernosal pressure.
  • RESULTS AND LIMITATIONS: Although the study included only 12 patients, every stimulation at all positions between 1 and 5 o'clock evoked urethral pressure responses in all patients.
  • CONCLUSIONS: We demonstrated that electrostimulation at not only the posterolateral but also the anterior and lateral circumference of the prostate capsule can increase cavernosal pressure.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Eur Urol. 2009 Jan;55(1):154-5 [18835087.001]
  • (PMID = 18835086.001).
  • [ISSN] 1873-7560
  • [Journal-full-title] European urology
  • [ISO-abbreviation] Eur. Urol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down






Advertisement